The slip
PARKINSON RECEIPTno. 8799
24 Oct 2026, 16:11 UTCdopamine neurons, braak
predictionDDX56 in dopamine neurons tracks Braak Lewy-body stage
registeredfc917dcbe580fbba
discovery+0.06 p=0.875 n=9
replication+0.21 p=0.586 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.06, p 0.875)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT20027da756e8350fe5ae3857…
follows ffbaba987f9b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8799: DDX56 in dopamine neurons, braak
- power
- full sample +0.13 (p 0.609, n 18), 95% CI -0.36 to +0.56. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.10 (p 0.683, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.08 (p 0.767, n 18). could be the mix.
- skeptic
- leave-one-out range +0.01 to +0.23, sign flips 0; without severely affected donors +0.13 (p 0.609, n 18). fragile.
- cell type
- strongest in astrocytes: -0.63 (p 0.0051, n 18) vs +0.13 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DDX56 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up DDX56 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.25 p 0.374 (needs p < 2.4e-4)